Yokomizo A, Shiota M, Morokuma F, Eto M, et al. GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401. Int J Urol 2023 Dec 26. doi: 10.1111/iju.15371.
PMID: 38148124